Clinical Analysis of Targeted Navel Drops in the Treatment of Diabetes Mellitus

Objective: To analyze and evaluate the clinical efficacy of targeted navel drops in the treatment of diabetes mellitus. Methods: The time span of the study was from September 2020 to April 2021, and 288 diabetic patients were selected from our hospital. The patients were divided into research group (n = 96) group, control group 1 (n = 96) and control group 2 (n = 96) by random number table. Control group 1 was managed with diet and exercise alone, control group 2 was treated with metformin on the basis of control group 1, and based on the treatment plan of the two control groups, the research group was treated with targeted navel drops. The relevant indexes of the three groups were compared and analyzed. Results: There was no significant difference in the fasting blood glucose and 2-hour postprandial blood glucose among the three groups (p > 0.05) before the treatment. After treatment, the fasting blood glucose and 2-hour postprandial blood glucose of the research group were significantly lower than those of control group 1 and control group 2 (p < 0.05). The total effective rate of the research group was 95.8%, that of control group 1 was 85.4%, and that of control group 2 was 79.2%. The total effective rate of the research group was significantly higher than that of control group 1 and control group 2 (p < 0.05). Conclusion: There is a significant effect of targeted navel drops on diabetic patients in reducing their blood sugar levels, and its curative effect is better than using a single hypoglycemic therapy belonging to western medicine. It can be widely promoted at all levels in medical institutions.